Blue Horseshoe Stocks: GLYC Breaks Out & More

GlycoMimetics, Inc. GLYC

The star of the show from yesterday’s premarket report was definitely GLYC, which we tagged in the extended watchlist after noticing the increasing accumulation and uptrend forming in recent sessions.

That trend was kicked into high gear with more than fifty-six times the three-month average volume pouring into the stock as GLYC traded up from a low of 7.21 and reached 11.58 for an intraday move of  61% The overall range we’ve seen here has been extended this morning in the premarket as well with the stock hitting a high of 12.05; that boosts our observed range to 67%

With GLYC shooting up so rapidly, we’ll want to be on the lookout for a potential dip-and-rip scenario, which we see quite a bit in these sort of situations.


Petroleo Brasiliero S.A. (Petrobras) PBR

It’s been awhile since we formulated an options idea for one of our old favorite targets in PBR, most recently being back in April. We often come back to the PBR well because it provides a lot of opportunities, and we’ve spotted what could be the next opportunity today.

Brazilian markets got crushed yesterday amid yet another government corruption scandal, causing a massive loss in share value for PBR in the blink of an eye. Today, it’s already snapping back and starting to recover in the premarket, so we want to formulate some options ideas to turn to in the event that the trend persists.

For quick-hit daytrading possibilities, we’ll have the PBR Weekly $8.50 and $9 Calls*, and for a longer-term idea we’ll have the PBR 06/30 $9.50 and $10 Calls on watch.
_____

Another Fresh Idea: Deere & Co. DE Weekly $118-121 Calls*
____

*Never attempt to trade weekly options on a Friday unless you are a highly experienced trader- it’s an exceedingly risky proposition.


Extended Watchlist:
ARNA, BRAV, DYN, ROSG, VNCE,

Blue Horseshoe Stocks: TBIO Review & More

Transgenomic, Inc. TBIO

TBIO was included in yesterday’s morning report, and the stock recorded a notable session with the help of a favorable press release. The stock started out from an early low of 1.58, and ran 29% to 2.04, dipped back to 1.77 before going on to hit its high of day at 2.11, an added 19% swing. Volume was immense, to the tune of more than nine times the 3-month average.

The news release from yesterday was pertaining to the company’s claim that they’ve developed the most comprehensive test to date for the diagnosis of Leukodystrophy, a disorder that has been notoriously difficult to diagnose; in many cases taking years. >>VIEW PR

There are a number of attractive features of the TBIO chart even after the considerable run it has enjoyed over the past few days- The strengthening RSI just broke the 50-line, and the MACD is gearing up for a bullish cross.


We’ll look for TBIO to continue registering higher lows, preferably above the 50DMA of 1.76, and for it to test resistance in the channel between yesterday’s high of 2.11 and the 200DMA of 2.15. TBIO certainly has a history of making breakout-type moves; twice this year the stock has traded for more than 3.50.


New Options Ideas

We’ve identified a couple of fresh options ideas to pass along to our readers this morning. For each of the following movers, we’ll be on the lookout for the occurrence of a dip-and-rip scenario Both stocks are gapping up here in the premarket.

FitBit, Inc. FIT

For FIT, we are going to monitor Weekly Calls (Friday Expiration) in the $45.50-48 range. We want to pay close attention to them the next couple of sessions as FIT has been establishing higher highs and higher lows on the chart. We’re watching for a dip from profit-taking, and subsequent rebound. If and when that happens, we should see some nice action in the range we highlighted.

Netflix, Inc. NFLX

As for NFLX, which has brought us serious options trading success in the past, we’re going to look for chances in Weekly Calls priced from $100-105. The stock just underwent a forward split, and there is some precedent for price increases following such an event (e.g. AAPL).


Extended Watchlist:
CLSN, OGXI, ATNM, FRO, ARNA, MILL(News)

Incoming search terms:

  • tbio speaking

Blue Horseshoe Stocks: Options, Bottom-Plays & More

GoPro, Inc. GPRO – Options

GPRO’s Q1 earnings beat on revenue and profits causing quite a surge in PPS. Yesterday the stock traded up from the $45-range to the $47-range, and this morning we’re observing a sizable gap-up, as GPRO has already changed hands for as much as 53.54 in the premarket.

In the midst of all this, we’ll be on the lookout for chances with GPRO Weekly Calls, most likely in the range from $49-51.50, with our strike price being dependent upon where the stock ultimately finds support off of this morning’s early highs.

It would fulfill a classic dip-and-rip scenario which by now, as our regular readers are well aware, is one of our favorite chart setups.


Windstream Holdings, Inc. WIN

We also want to point out the nice intraday move made by WIN following its inclusion in yesterday’s extended watchlist. The stock briefly touched a morning low of 10.71, before running 22% to a high of 13.05 on just under 4X its 3-month average volume.

The move came on the heels of upgrades for the stock from a number of Wall St. analysts, and over at one of our favorite data reference sites, BARCHART.COM, GPRO is currently receiving an 80% Short-Term “Buy” Rating.


LifeApps Digital Media, Inc. LFAP

LFAP is a potential subpenny bottom-play that is catching our attention this morning, and we wanted to pass it along to our readers. We’re always on the lookout for stocks trading at or near their 52-week lows, and not only does this one fit that bill, but the company also released some interesting news this morning.

At this price-point and in this situation, there’s always a chance for a nice rebound to provide quality opportunities for quick-strike trades.

SAN DIEGO, CA–(Marketwired – Apr 29, 2015) – LifeApps Digital Media Inc. (OTC PINK: LFAP) (“LifeApps”), an emerging growth company, and designer of m-health, fitness and sports applications (“apps”) has updated MDWorkout® its popular health app for Apple iPhone and iPad with integration with Apple HealthKit. >> FULL PR


Extended Watchlist:
MLER, ONCY, MCGC, GNW, ARNA

Blue Horseshoe Stocks: BIND Recap & More

BIND Therapeutics, Inc. BIND

BIND cropped up on our premarket scanner yesterday in the wake of a post-market PR on Wednesday afternoon, and it put forth a solid move early in the session. It traded as low as 7.40 at the open, and we then witnessed a significant 36% spike to the high-of-day at 10.04.

That initial run was fueled by the release of positive Phase-2 results from one of the company’s many cancer treatments currently in various trial phases, and additionally, an update on guidance for 2015.  >>> READ PR

According to the CEO, BIND expects 2015 “to be a particularly active period” with regard to the development of its many products, so this will be a play that we’ll want to monitor more closely moving forward.

Toward the end of the session yesterday BIND pulled back, and is gapping once again in the pre-market, so we have our eyes peeled for any potential bounce action that could be used in our favor.


Twitter, Inc. TWTR – Options

We’ve also got to update everyone on the options trading idea we put forth earlier this week for TWTR. We mentioned an interest in the Weekly $38 and $39 Calls, and each set of contracts showed us a huge spike during yesterday’s session.

The $38′s traded in a range from .23-1.22, for a chance at monstrous gains of up to 430%, while the $39′s did even better as they ripped from .09 to a high of .54, a move totaling 500%

We also wanted to remind readers of the long-term options idea for TWTR we mentioned in the same report. The February $40 Calls could be in line for significant gains if TWTR continues to recover off of recent lows in the $35-36 range.


Extended Watchlist:
AGEN, CERE, ARNA, SD, NVAX, CARA

Incoming search terms:

  • why did BIND stock spike Friday?

Blue Horseshoe Stocks: ARNA Recap & More

Arena Pharmaceuticals, Inc. ARNA

You have to go a long way back to find our very first coverage of ARNA. It was May 11th, 2012 that we first mentioned this stock as an item to have on long-term watch. At that time the company had an obesity treatment that was awaiting FDA approval.

The public sentiment during that summer was that FDA approval was all but in the bag, and as we waited the stock began a monstrous run from a low of 5.44 to the day of its approval when it hit 13.50, an overall increase of 148% It would be a very long time before we talked about ARNA again.

The next time was fairly recently on November 3rd when we included ARNA on our Extended Watchlist, and over a period of a few sessions, saw the stock make a decent move from a low of 4.12 to 4.76. After that, it endured a series of incremental pullbacks over the next several weeks.

Yesterday morning, in a stroke of superb timing we tagged the stock in our watchlist once again, and what it did next blew the run we witnessed in November right out of the water!  Coinciding with the announcement of positive top-line results on another of the company’s treatments (this one for autoimmune disease) ARNA made a huge intraday run from a low of 3.66 to all the way up to 6.09. That’s a hefty 66% increase in a single session, and it came on approximately 20X the 3-month average volume, so cheers are in order for anyone who took advantage of our timely alert!


Heritage Media Corp. HMCP

Since we mentioned HMCP for the first time on New Year’s Eve, the stock has provided us with a few quality swing-trade opportunities. That day the stock traded in a range from .0047 to .0068, an intraday gain of 45% In following sessions we then observed subsequent swings from .0037-.0064 (+73%) and .0034-.0062 (+82%) making HMCP a flipper’s dream.

As we point out on the snapshot below, what has formed on the chart is known as a bullish flag, which is known to be a signal of further gains. Couple that with an RSI that’s screaming toward the power zone, and it makes HMCP one that we’ll really need to watch closely as we head into week’s end.


Extended Watchlist:
BIND, BIOD, FOLD, NRX, CYRN, AVEO, ACUR, PLX, S